glp-1 in nature GLP-1-based therapies for diabetes, obesity and beyond 1 pathway Mapping the effectiveness and risks

Garg and team

doi:10.1158/1078-0432.CCR-21-0715 136

Upon activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), berberine enhances insulin sensitivity, reduces hepatic glucose output, and has been shown in animal models to increase GLP-1 secretion, although this mechanism has not yet been confirmed in large human trials

Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions

New patient with binge eating disorder and obesity

Proper nutrition, adequate protein intake, and movement help preserve lean muscle while using semaglutide for men Chicago or zepbound for men Chicago